Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA

Endpoints NewsOtsuka touts new IgAN evidence as it seeks full approval for Voyxact

AgilentA Look At Agilent Technologies (A) Valuation As FDA Approval AI Deal And Earnings Update Draw Focus - simplywall.st

Endpoints NewsActing FDA chief isn't interested in permanent role

Clinical OMICsPost-Stroke Arm Immobility Improved with Spinal Cord Stimulation

Lonza NewsStipple Bio and Lonza Agree to Focus on Advancing Oncology ADC Therapies - Genetic Engineering and Biotechnology News

Clinical OMICsInfant Brain Development Sheds Light on Parkinson’s Link with Autism

Clinical OMICsAlzheimer’s Genetic Risk Loci: 16 New Candidates

Endpoints NewsActing FDA commissioner pledges to prevent political interference in rare disease meeting

Endpoints NewsDimension seeks up to $750M for third life sciences fund after string of success

Endpoints NewsElevance talks 'practical' AI

Endpoints NewsMammalian hair, roof leaks: Novo Nordisk's site in Indiana under FDA scrutiny once again

Endpoints NewsMammalian hair, roof leaks: Novo's Catalent site in Indiana under FDA scrutiny once again